Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate

Allergic Rhinitis and Its Impact on Asthma

2001 • 3,508 citations

Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper☆☆☆★★★♢

1998 • 1,602 citations

Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study)

2002 • 1,062 citations

Immunotherapy with a standardized extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children

1997 • 571 citations

Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six‐year follow‐up study.

2001 • 545 citations

Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.

1993 • 479 citations

Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-γ

1996 • 420 citations

Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs.

1991 • 390 citations

Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study

2001 • 282 citations

Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy☆☆☆★★★

1997 • 237 citations

Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study.

1990 • 226 citations

Allergic factors associated with the development of asthma and the influence of cetirizine in a double‐blind, randomised, placebo‐controlled trial: First results of ETA®

1998 • 212 citations

Double‐blind, placebo‐controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization

1998 • 190 citations

Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial

2002 • 186 citations

The kinetics of change in cytokine production by CD4+ T cells during conventional allergen immunotherapy

1999 • 108 citations

Sublingual immunotherapy: a double‐blind, placebo‐controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both

1999 • 108 citations

The safety and efficacy of subcutaneous birch pollen immunotherapy - a one-year, randomised, double-blind, placebo-controlled study

2002 • 96 citations

The relationships between late cutaneous responses and specific antibody responses with outcome of immunotherapy for seasonal allergic rhinitis

1989 • 54 citations

The effect of immunotherapy on the cutaneous late phase response to antigen

1994 • 53 citations

Epidemiology of asthma

1993 • 48 citations

Rush sublingual immunotherapy in Parietaria allergic patients.

1996 • 33 citations

Collaborative clinical assay of the biological potency of allergen skin‐test extracts

1984 • 24 citations

Efficacy and safety of fluticasone propionate 250 μg administered once daily in patients with persistent asthma treated with or without inhaled corticosteroids

2002 • 20 citations

Fluticasone for the treatment of symptomatic bronchial asthma in children treated with sodium cromogylate--a prospective, randomised trial.

2002 • 3 citations